What causes high estradiol in men?

Elevated estradiol in men is most commonly caused by excess aromatase activity in adipose tissue converting testosterone to estrogen (obesity-driven), over-replacement with testosterone therapy without aromatase inhibitor management, SHBG changes that alter free estrogen availability, certain medications (anabolic steroids, some blood pressure drugs), liver dysfunction impairing estrogen clearance, and alcohol excess.

Lab Reference Library / Estradiol Hormones

Estradiol

Q: What is the optimal estradiol level for women?

Optimal estradiol levels for women vary by phase of the menstrual cycle. During the follicular phase (days 1 to 13), levels of 50 to 150 pg/mL are typical and adequate. At ovulation (day 14), levels peak to 150 to 400 pg/mL. During the luteal phase (days 15 to 28), levels of 75 to 250 pg/mL reflect healthy progesterone production alongside estradiol. In functional medicine, the goal is not a single target but appropriate cycling with adequate mid-cycle peak and luteal support.

Q: What does low estradiol cause in women?

Low estradiol in women causes hot flashes and night sweats, vaginal dryness and painful intercourse, reduced libido, mood changes and depression, poor sleep quality, cognitive difficulties and brain fog, accelerated bone density loss, elevated cardiovascular risk, dry skin and hair thinning, and joint pain. These symptoms occur both in surgical menopause and in natural perimenopause and menopause as ovarian estrogen production declines.

Q: What is the optimal estradiol level for men?

In functional medicine, optimal estradiol for men is generally 20 to 40 pg/mL. Estradiol is essential for male bone density, cardiovascular health, libido, and cognitive function. Men with estradiol below 20 pg/mL experience symptoms including joint pain, reduced libido, bone loss, and emotional instability. Men with estradiol above 50 pg/mL may experience gynecomastia, reduced libido, water retention, and suppression of testosterone production.

E2 · 17-Beta Estradiol · Estrogen

Reference range, optimal functional medicine levels, and why estradiol, the most biologically potent estrogen, is critical for bone density, cardiovascular health, cognitive function, mood, and sexual health in both women and men.

Most SearchedHormone Marker

Standard (W, follicular)27 to 161 pg/mL

FM Optimal (W, mid-cycle)150 to 300 pg/mL

FM Optimal (M)20 to 40 pg/mL

Unitspg/mL

← Back to Lab Reference Library

Category: Hormones | Also known as: E2, 17-Beta Estradiol, Estrogen | Sample: Serum; timing relative to menstrual cycle is critical for women

1. What This Test Measures

Estradiol (E2) is the most biologically potent of the three estrogens (estradiol, estrone, and estriol) and the primary estrogen produced by the ovarian granulosa cells in premenopausal women. In men, estradiol is produced by peripheral aromatization of testosterone in adipose tissue, liver, and other tissues. In postmenopausal women, estradiol is produced primarily through peripheral aromatization of adrenal androgens.

Unlike estrone (E1) and estriol (E3), estradiol has the highest affinity for estrogen receptors throughout the body and is the dominant driver of estrogenic effects in reproductive-age women. Estrogen receptors (ERalpha and ERbeta) are expressed in virtually every organ system:

Bone: estradiol is the primary regulator of osteoclast activity and bone density preservation
Cardiovascular: protects endothelial function, promotes vasodilation, and regulates lipid metabolism
Brain: neuroprotective, supports serotonin and dopamine signaling, and protects cognitive function
Genitourinary: maintains vaginal epithelium, lubrication, and bladder health
Metabolic: influences insulin sensitivity, fat distribution, and inflammatory tone

Estradiol fluctuates substantially across the menstrual cycle, making the timing of blood draw critical for accurate interpretation. Testing must be referenced to cycle day to be clinically meaningful.

2. Why This Test Matters

Bone density: estradiol is the single most important hormone for maintaining bone mineral density in both women and men. Estradiol deficiency accelerates bone resorption, producing osteopenia and ultimately osteoporosis. In women, bone loss accelerates dramatically in perimenopause and early menopause as estradiol declines.
Cardiovascular protection: premenopausal women have dramatically lower cardiovascular risk than men of equivalent age, a difference largely attributable to estradiol's protective effects on endothelial function, lipid profiles, and arterial elasticity. After menopause, cardiovascular risk rises rapidly as estradiol declines.
Cognitive health: estradiol supports neuronal survival, synaptic plasticity, and neurotransmitter function. Low estradiol is associated with brain fog, memory difficulties, depression, and anxiety. The timing of menopausal hormone therapy initiation (the "critical window" or "timing hypothesis") suggests that early estradiol replacement at menopause onset reduces Alzheimer's disease risk.
Menstrual cycle regulation: estradiol drives endometrial proliferation in the follicular phase and triggers the LH surge at ovulation. Abnormal estradiol levels disrupt cycle regularity, fertility, and ovarian function assessment.
Men's health: estradiol in men maintains bone density, supports libido, protects cardiovascular function, and contributes to cognitive health. Both deficiency (below 20 pg/mL) and excess (above 50 pg/mL) produce clinical problems in men.
Estrogen dominance: even when absolute estradiol is not elevated, a relative excess of estradiol compared to progesterone drives a clinical pattern of heavy periods, breast tenderness, weight gain, bloating, and mood instability that is one of the most common hormonal presentations in perimenopausal women.

3. Standard Lab Reference Range

Population / Phase	Standard Range	Units
Women, follicular phase (days 1 to 13)	27 to 161	pg/mL
Women, ovulatory peak (day 14)	97 to 433	pg/mL
Women, luteal phase (days 15 to 28)	49 to 291	pg/mL
Women, postmenopausal	Below 10 to 40	pg/mL
Men (adult)	8 to 35	pg/mL

Reference ranges must always be interpreted in the context of cycle day for premenopausal women. A follicular phase estradiol of 45 pg/mL is appropriate; a luteal phase estradiol of 45 pg/mL may indicate inadequate luteal support. Always document the cycle day when ordering estradiol.

4. Optimal Functional Medicine Range

Phase / Population	Functional Medicine Optimal	Clinical Notes
Women, early follicular	40 to 100 pg/mL	Rising from baseline; adequate ovarian stimulation
Women, mid-cycle peak	150 to 400 pg/mL	Triggers LH surge and ovulation; below 150 may impair ovulation
Women, mid-luteal	100 to 250 pg/mL	Sustained with progesterone; below 80 suggests poor luteal support
Women, postmenopause on HRT	50 to 100 pg/mL	Symptom relief with bone and cardiovascular protection
Men	20 to 40 pg/mL	Optimal for bone density, libido, and cognitive function

5. Symptoms Associated With Abnormal Estradiol

Low Estradiol (Women)

Hot flashes and night sweats
Vaginal dryness, itching, and painful intercourse
Reduced libido and sexual interest
Depression, anxiety, and irritability
Poor sleep quality and insomnia
Brain fog, memory difficulties, and cognitive slowing
Accelerated bone density loss and joint pain
Elevated LDL and cardiovascular risk increase
Dry skin, hair thinning, and brittle nails
Irregular or absent menstrual cycles
Reduced exercise capacity and muscle recovery

Elevated Estradiol / Estrogen Dominance

Heavy, prolonged, or irregular menstrual periods
Breast tenderness and fibrocystic breast changes
Bloating and water retention
Weight gain, particularly hips and thighs
Mood swings, irritability, and anxiety
PMS symptoms worsening premenstrually
Uterine fibroids and endometriosis activity
In men: gynecomastia, reduced libido, water retention
In men on TRT: estradiol excess from excessive aromatization
Fatigue and reduced thyroid function (estrogen impairs T4-to-T3 conversion)

6. What Causes Abnormal Estradiol

Causes of low estradiol

Menopause and perimenopause: declining ovarian follicular reserve reduces estradiol production; the most common physiological cause
Premature ovarian insufficiency (POI): loss of ovarian function before age 40; autoimmune, genetic, or iatrogenic causes
Hypothalamic amenorrhea: chronic stress, excessive exercise, or severe caloric restriction suppresses GnRH and downstream estradiol production
Hyperprolactinemia: elevated prolactin (from pituitary adenoma or medications) suppresses the HPG axis and reduces estradiol
Excessive aromatase inhibitor use: in TRT patients; over-suppression of estradiol causes bone pain, joint pain, and reduced libido
Primary ovarian insufficiency: chemotherapy, radiation, or autoimmune oophoritis

Causes of elevated estradiol

Obesity: excess adipose tissue drives aromatase activity, converting androgens to estrogens; a primary driver of estrogen excess in both sexes
In men on TRT: excess testosterone converts to estradiol via aromatase without adequate monitoring or management
PCOS: chronic anovulation leads to persistent follicular estradiol without cyclical progesterone opposition
Liver dysfunction: impaired hepatic estrogen clearance allows accumulation
Alcohol excess: stimulates aromatase and impairs liver-mediated estrogen metabolism
Exogenous estrogen: hormone replacement therapy, oral contraceptives, or environmental xenoestrogens
Stress and cortisol: cortisol competes with progesterone receptors and impairs progesterone production, creating relative estrogen dominance

7. How to Improve This Marker

For Low Estradiol

Ensure adequate caloric intake; hypothalamic amenorrhea from undereating is the most reversible cause of estradiol deficiency in young women
Reduce excessive exercise if contributing to hypothalamic suppression
Address chronic stress; cortisol excess suppresses GnRH and downstream estradiol
Phytoestrogens (soy isoflavones, flaxseed lignans) provide weak estrogenic activity; evidence-based for mild menopausal symptom relief
For men: review aromatase inhibitor dosing if over-suppressing estradiol
Optimize DHEA-S; adrenal androgens are the primary precursor to estradiol in postmenopausal women

For High Estradiol / Estrogen Dominance

Weight loss; reducing adipose tissue directly reduces aromatase activity
Cruciferous vegetables (broccoli, cauliflower, Brussels sprouts): contain DIM and indole-3-carbinol which support estrogen metabolism through the 2-hydroxy pathway
Reduce alcohol; directly impairs hepatic estrogen clearance
Optimize liver function; the liver is responsible for estrogen conjugation and excretion
Increase dietary fiber; promotes fecal estrogen excretion and reduces enterohepatic recirculation
Minimize xenoestrogen exposure: BPA, phthalates, pesticides; use glass, stainless steel, and organic produce where possible

Medical Options

Bioidentical estradiol (HRT): transdermal patches, gels, or creams are strongly preferred over oral; transdermal delivery bypasses first-pass liver metabolism, avoids increased clotting risk, and provides more stable levels
Vaginal estradiol: for genitourinary syndrome of menopause; minimal systemic absorption; highly effective for vaginal dryness and bladder symptoms
Always pair with progesterone: in women with a uterus, estradiol must be balanced with bioidentical progesterone to protect the endometrium and counteract estrogen's proliferative effects
Aromatase inhibitors (men on TRT): anastrozole or exemestane to manage excessive estradiol conversion from testosterone; use the minimum effective dose; over-suppression causes joint pain and bone loss
DIM (diindolylmethane): 200 to 400mg daily; supports 2-hydroxy estrogen metabolism pathway; useful for estrogen dominance
Calcium-D-glucarate: inhibits beta-glucuronidase enzyme in gut, reducing reabsorption of conjugated estrogens

8. Related Lab Tests

ProgesteroneEssential Estradiol Counterbalance

→

SHBGDetermines Free Estradiol Availability

→

Total TestosteroneTestosterone Converts to Estradiol

→

DHEA-SAdrenal Estradiol Precursor

→

LHTriggers Ovulation; Estradiol Drives LH Surge

→

FSHRises as Estradiol Declines with Aging

→

9. When Testing Is Recommended

Women with menopausal symptoms: hot flashes, night sweats, vaginal dryness, mood changes, or sleep disruption
Irregular, heavy, or absent menstrual cycles
Fertility evaluation; estradiol on cycle day 3 assesses ovarian reserve alongside FSH and AMH
Perimenopausal transition monitoring; estradiol fluctuations precede TSH and FSH changes
Monitoring hormone replacement therapy; ensures therapeutic levels without excess
Men with symptoms of gynecomastia, reduced libido, water retention, or fatigue on TRT
Evaluation of osteoporosis risk; low estradiol is a primary driver of bone density loss in both sexes
PCOS evaluation alongside testosterone, SHBG, and LH/FSH ratio
Any comprehensive functional medicine hormone panel

10. Clinical Perspective

Clinical Perspective

Estradiol is the hormone that gets blamed for everything and credited for almost nothing. In my practice I see two recurring patterns. The first is women in their late 40s or early 50s being told estrogen is dangerous because of studies using synthetic progestins paired with conjugated equine estrogen, which is not the same as bioidentical estradiol paired with bioidentical progesterone. The second is men on testosterone therapy whose estradiol has been crushed to 12 pg/mL by an aggressive aromatase inhibitor protocol, and they are complaining of joint pain, bone loss, and mood instability that their provider attributes to something else entirely. Estradiol is a critical hormone in both sexes. In women it protects the brain, the heart, and the skeleton. In men it does the same. The goal is not elimination or suppression. The goal is optimization within a physiological range, in balance with progesterone in women and in balance with testosterone in men.

Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma

11. Frequently Asked Questions

What is the optimal estradiol level for women?

Optimal estradiol levels for premenopausal women vary by cycle phase: 40 to 100 pg/mL in the early follicular phase, 150 to 400 pg/mL at mid-cycle peak, and 100 to 250 pg/mL in the mid-luteal phase. For postmenopausal women on hormone therapy, 50 to 100 pg/mL typically provides symptom relief with bone and cardiovascular protection. Always interpret estradiol relative to the cycle day drawn.

What does low estradiol cause in women?

Low estradiol causes hot flashes and night sweats, vaginal dryness and painful intercourse, reduced libido, depression and anxiety, poor sleep, cognitive difficulties, accelerated bone density loss, elevated cardiovascular risk, dry skin, and hair thinning. These symptoms appear in natural perimenopause, surgical menopause, hypothalamic amenorrhea, and premature ovarian insufficiency.

What is the optimal estradiol level for men?

In functional medicine, optimal estradiol for men is 20 to 40 pg/mL. Estradiol is essential for male bone density, libido, cognitive function, and cardiovascular health. Men with estradiol below 20 pg/mL experience joint pain, reduced libido, and bone loss. Men with estradiol above 50 pg/mL may experience gynecomastia, water retention, and suppression of testosterone production.

What is estrogen dominance?

Estrogen dominance refers to a state in which estradiol is elevated relative to progesterone, regardless of whether absolute estradiol levels are within the normal range. It is associated with heavy or irregular periods, breast tenderness, bloating, weight gain in hips and thighs, mood swings, PMS, fibrocystic breasts, and uterine fibroids. Addressing estrogen dominance requires optimizing progesterone alongside estradiol, supporting liver detoxification, and reducing xenoestrogen exposure.

Is bioidentical estradiol safer than synthetic estrogen?

Bioidentical estradiol (17-beta estradiol) is chemically identical to the estrogen produced by the human ovary. The large studies that raised concerns about HRT safety (primarily the Women's Health Initiative) used conjugated equine estrogens and synthetic medroxyprogesterone acetate, not bioidentical hormones. Transdermal bioidentical estradiol paired with bioidentical progesterone has a more favorable safety profile regarding blood clot risk and breast tissue effects than the synthetic formulations studied in older trials.

Why does estradiol affect bone density?

Estrogen receptors are expressed on osteoclasts (cells that break down bone) and osteoblasts (cells that build bone). Estradiol directly inhibits osteoclast activity, preventing excessive bone resorption. When estradiol declines at menopause, osteoclast activity accelerates dramatically, causing rapid bone density loss in the first 3 to 5 years following menopause. This is why estrogen replacement initiated at menopause is one of the most effective interventions for osteoporosis prevention.

Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.

Estradiol protects the brain, heart, and skeleton. In both sexes.

Whether you are experiencing menopausal symptoms, managing bone density, or optimizing testosterone therapy, estradiol is a critical part of the picture. Schedule a consultation for a complete hormone evaluation.

Schedule a Consultation

Medical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.